CLINICAL_TRIALS
trial_result
· 2025-03-21
Clinical Trial Update: Risperidone for the Treatment of Huntington's Disease Involuntary Movements [Phase 2]
Summary
Phase 2 trial evaluating risperidone for involuntary movements in Huntington's disease (chorea) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Huntington Disease, Chorea | Phase 2 | Status: COMPLETED | Results posted: 2025-03-21